TherapySelector - Google Play
You'll be able to see results in few seconds.
Publisher Description
The app for physicians to choose a person-centered treatment for their patient
TherapySelector supports you as a physician to easily and quickly choose a data-based, person-centered treatment for hypertension and hepatitis C for and with your patient during consultation hours.The app shows in a single glance information about the effectiveness of medication based on the disease remission (systolic blood pressure of < 140 mmHg for hypertension and viral clearance in hepatitis C), the likelihood of adverse events, cost and patient group size. This overview allows you to easily and quickly decide on the best person-centered treatment method for your patient, based on study data.
How does TherapySelector work?
First you enter the requested characteristics of your patient by answering 4 simple questions about etiology, disease stage, previous treatments and comorbidities. Based on this, a profile of the patient is determined. The app then shows an overview of all registered treatments for that specific patient profile, based on frequently updated study results. For each therapy you find information about effectiveness, possible adverse events and costs.
TherapySelector currently provides the following features:
• Determination of patient profiles based on four simple questions about the patient.
• Probability of "success" of all registered medication (combinations) for hypertension and hepatitis C, together with the probability of adverse events associated with the patient profile, based on individual patient data from key clinical scientific studies.
• For hypertension: overview of therapy options with Thiazide diuretics (THZ), Calcium Channel Blockers (CCA), ACE inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB). Information on monotherapy with dose increase (Titrate), and results of stepwise addition of medication (Titrate & Add).
• Detail information, including information about dosage (of the therapy regime) and the cost of a specific treatment.
• Availability in both English and Dutch.
TherapySelector is intended to provide physicians and patients person-centered information to support them in choosing the most appropriate treatment. In doing so, the app complements guidelines that are based on the ‘average’ patient. TherapySelector can be used without creating an account.
Developed with (academic) medical centers and research institutes
TherapySelector is developed in collaboration with physicians and scientists associated with universities and leading academic medical centers such as the Erasmus MC, LUMC and MUMC+. The data has been authorized by specialists from Dutch scientific associations.
The results in the app are calculated using anonymous patient data from scientific studies of published randomized controlled trials, other phase 2 & 3 studies and prospective real-life studies around the world (high quality research). Research groups and sponsors make their data available for this purpose.
About TherapySelector
TherapySelector B.V. is a social enterprise. Our mission is to improve health care globally by enriching it with person-centered treatment information based on the most recent data from scientific studies. It is not our goal to make profit.
With the TherapySelector app, we facilitate doctors with person-centered care to achieve health gains for their patients. Additionally, we want to aid in controlling the rising costs of healthcare for the public, e.g. by preventing over- and under-treatment.
Follow us on
www.therapyselector.com
.
About TherapySelector
The company that develops TherapySelector is TherapySelector. The latest version released by its developer is 1.0 .
To install TherapySelector on your Android device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2026-02-10 and was downloaded 0 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the TherapySelector as malware as malware if the download link to com.liverdoc.hcvts is broken.
How to install TherapySelector on your Android device:
- Click on the Continue To App button on our website. This will redirect you to Google Play.
- Once the TherapySelector is shown in the Google Play listing of your Android device, you can start its download and installation. Tap on the Install button located below the search bar and to the right of the app icon.
- A pop-up window with the permissions required by TherapySelector will be shown. Click on Accept to continue the process.
- TherapySelector will be downloaded onto your device, displaying a progress. Once the download completes, the installation will start and you'll get a notification after the installation is finished.
Program Details
System requirements
Download information
Pricing
Version History
version
posted on 2026-02-10
UI updates
version 4.1.2
posted on 2025-03-21
New in this release:
• Text changes
version 4.1.1
posted on 2024-09-11
New in this release:
• Small bug fixes
• Addition of data from over 5,000 patients from the SHEP study
version 4.1.0
posted on 2024-04-29
New in this release:
• Change of the patient profile for Hypertension; African descent is no longer included as an option given the scientific discussion of race as a predictive factor
• Addition of data from over 50,000 patients from the ALLHAT and VALUE studies
We also launched TherapySelector as web application. Via app.therapyselector.com, you can use TherapySelector directly from your browser.
version 4.0.19
posted on 2024-01-23
New in this release:
- Clearer explanation in results screen of hypertension: the text is enriched with visual elements
- Equivalence tables: directly accessible from the results screen and details screen to easily translate the study medication to your preferred medication
- Terms of use: we value transparency when using the app
Do you have comments or encounter problems? Use the new feature to rate the app.
version 4.0.18
posted on 2023-11-14
After introducing Patient profile Suggestions for hepatitis C, in this release we are also launching Patient profile Suggestions for hypertension. If not enough data is available for your chosen patient profile, we now provide several suggestions. These suggestions are based on patient profiles where one patient characteristic has been removed from the profile.
We have also made some minor adjustments to the patient profile options for hypertension.
version 4.0.17
posted on 2023-09-27
We are launching some major changes.
• Suggestions Hepatitis C: If there is not enough data available for your chosen patient profile, we now provide several suggestions. These suggestions are based on patient profiles with one patient characteristic omitted.
• Pre-release Hypertension: hypertension has been added as a pre-release. You can already use this in practice, although more data is needed for a full overview of therapy choices. We are currently processing data from over 60,000 patients.
version 4.0.16
posted on 2023-06-02
In this release, we have made the following improvements:
• We made it easier for you to select a patient profile by introducing a dropdown.
• In the detail screen, you can collapse and expand the accordions all at once.
• The loading of the screens is now faster.
If you have any remarks or issues, please send us your feedback via the app.
version 4.0.15
posted on 2023-03-22
We have made several improvements in this release:
- The design of the detail screen has been changed. This allows you to see at a glance the dosage per tablet with the correct daily dosage.
- Improved readability by changing the font in some places.
- You can now see whether there are results with or without Ribavirin.
Additional data has been loaded from the HCV-TARGET study: a total of 190 patients have been added.
version 4.0.11
posted on 2022-05-04
In this release:
. The app and database have been completely renewed, and are now generic for several diseases.
. The data for hepatitis C has been updated. The database now contains 52,000 patients with registered DAA treatment. Data on therapy regimes with (peg)Interferon, Simeprevir, Paritaprevir or combinations thereof are no longer included.
. Small improvements have been made to improve the user experience such as additional explanatory texts and a list of all references.
Disclaimer
Official Google Play Link
We do not host TherapySelector on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Google and passed their terms and conditions to be listed there. We recommend caution when installing it.
The Google Play link for TherapySelector is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
